Is Stenting an Appropriate Therapy in Women Presenting with Acute Coronary Syndrome? A Pathologist's Perspective

Masataka Nakano1, Fumiyuki Otsuka1, Renu Virmani1

  • 1CVPath Institute, 19 Firstfield Road, Gaithersburg, MD 20878, USA.

Insights

This review examines the pathology of drug-eluting stents (DES) in patients who died suddenly after coronary artery disease treatment. It analyzes findings from early and late time points after stent implantation.

Area of Science:

  • Cardiovascular Pathology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Percutaneous transluminal coronary angioplasty has treated coronary artery disease for over 30 years.
  • Bare metal stents and drug-eluting stents (DES) have improved clinical outcomes.
  • DES reduce acute vessel closure and restenosis rates.

Purpose of the Study:

  • To review the pathologic findings of coronary stents in patients who died suddenly.
  • To analyze early (<30 days) and late (>30 days) findings after DES implantation.
  • To compare findings in male and female patients.

Main Methods:

  • Review of autopsy findings in patients with coronary stents.
  • Analysis of cases with acute coronary syndrome.
  • Categorization of findings based on time after DES implantation (early vs. late).

Main Results:

  • Pathologic findings related to stent implantation in sudden death cases.
  • Identification of complications associated with DES.
  • Comparison of early and late stent-related pathologies.

Conclusions:

  • Understanding stent pathology is crucial for improving outcomes in coronary artery disease treatment.
  • DES have significantly impacted clinical results, but complications can still occur.
  • Further research into long-term DES performance and pathology is warranted.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
567
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
419